| Financial Year |
March 31 2023 |
| Monetary Funds |
160,998,177.45 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
12,561,443.40 |
| Accounts Receivable |
475,276,679.36 |
| Advances to Suppliers |
1,146,294.02 |
| Other Receivables |
15,911,053.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
501,789,055.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,486,532.36 |
| Total Current Assets |
1,275,300,720.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
13,549,886.09 |
| Investment Properties |
-- |
| Fixed Assetes |
192,206,915.01 |
| Under-construction Projects |
370,500.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
35,772,630.88 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
765,981.34 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
57,828,888.55 |
| Sub-Total of Non-Current Assets |
364,580,044.80 |
| Total Assets |
1,639,880,765.25 |
| Short-Term Loans |
674,295,408.03 |
| Trading Financial liabilities |
-- |
| Notes Payable |
118,774,578.22 |
| Accounts Payable |
254,168,517.68 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,083,861.48 |
| Taxes Payable |
814,192.85 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
18,912,132.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
531,325.56 |
| Other Current Liabilities |
4,814,077.53 |
| Sub-Total of Current Liabilities |
1,114,009,136.11 |
| Long-term Loans |
22,800,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
66,672,945.67 |
| Total Liabilities |
1,180,682,081.78 |
| Paid-In Capital(Or Share Stock) |
262,080,000.00 |
| Capital Surplus |
23,770,128.63 |
| Surplus Reserve |
46,438,712.32 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
157,865,873.45 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
459,198,683.47 |
| Owner's Equity（Stockholder's Equity） |
459,198,683.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,639,880,765.25 |
